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BACKGROUND:  We  describe  an  unusual  case  of 2  intra-parenchymal  breast  melanomas  with  a concomi-
tant  subcutaneous  melanoma  in the ipsilateral  upper  limb  and  no  deﬁnite  primary  lesion.
CASE  REPORT:  Our patient  is a 40-year-old  Chinese  female  who  presented  with  a  breast  lump  in  her  left
breast for which  excision  biopsy  showed  melanoma.  A PET-CT  revealed  a second  lesion  in her  breast.
A  left  upper  arm  nodule  with  no  overlying  skin  changes  was  also  noted.  She  underwent  a mastectomy
and  excision  biopsy  of  the  upper  arm  nodule.  Histology  showed  that  the second  breast lesion was  also  aelanoma
reast
ancer
ntra-dermal
melanoma,  while  the arm  nodule  contained  melanoma  cells  within  a ﬁbrous  capsule.
CONCLUSION:  The  presence  of a melanoma  in  the  breast  should  prompt  a close  and  meticulous  search  for
a primary  lesion  and  potential  signs  of metastasis.  Encapsulated  subcutaneous  nodules  can  be  attributed
to  replaced  lymph  nodes  or subcutaneous  melanoma  which  can  be either  primary  dermal  melanoma  or
own  p
 Publi
he  CCelanoma-in-transit metastasis  from  an  unkn
© 2016  The  Authors.
access  article  under  t
. Introduction
Metastatic malignancies to the breast are uncommon. One of the
ore common tumors that metastasize to the breast is malignant
elanoma. Primary dermal melanoma is a term used to describe
elanoma conﬁned to the dermis or subcutaneous tissue without
n epidermal component. In this report, we describe an unusual
ase of 2 intra-parenchymal breast melanomas with a concomitant
ubcutaneous melanoma in the ipsilateral upper limb with no deﬁ-
ite primary lesion. This report is written in accordance to the CARE
riteria [1].
. Case study
Mrs  T is a 40 year-old Chinese female who presented to us in
une 2013 with a left breast lump in the upper inner quadrant
f one month’s duration. Physical examination showed a mobile,
ell-deﬁned palpable nodule in her left breast. She did not have
ther nodules or pigmented lesions. A mammogram and ultra-
ound showed a 15 mm benign-looking left breast nodule which
as ovoid and well-deﬁned. This was observed as the nodule
ppeared benign. However, there was a slow increase in the size
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of the nodule and the follow-up mammogram and ultrasound in
August 2014, 14 months later, showed that it had increased in size
to 24 mm,  was  lobulated, and associated with increased vascular-
ity. She presented to our center in September 2014 for treatment.
The nodule was noted to be well-deﬁned and mobile. We decided
to proceed directly to an excision biopsy instead of a ﬁne needle
aspiration cytology (FNAC) as the clinical and radiological features
in a young patient suggested strongly at a diagnosis of ﬁbroade-
noma. Intra-operative ﬁndings showed a 2.5 cm nodule in the upper
inner quadrant of the left breast, which was encapsulated and well-
deﬁned. Gross examination revealed a homogenous yellowish-tan
cut surface without any hemorrhage or necrosis (Fig. 1). His-
tology revealed a lobulated proliferation of sheets of epitheloid
cells featuring enlarged vesicular nuclei, conspicuous nucleoli and
ample eosinophilic cytoplasm, accompanied by scattered intra-
cytoplasmic brownish pigment (Fig. 2A and B). Focally the tumor
cells display eccentric nuclei with hyaline cytoplasmic inclusions
(Fig. 2C), giving rise to a rhabdoid morphology. The tumor cells
showed strong and diffuse staining for S100 and melan-A with focal
positivity for HMB45 (Fig. 2D–F), establishing their melanocytic lin-
eage. Multiple keratin markers were all negative. A diagnosis of
melanoma with rhabdoid features was  made. The tumor was nega-
tive for EWSR1 translocation on ﬂuorescence in situ hybridization
(FISH), hence a clear cell sarcoma was  excluded.In view of this histology, a PET-CT scan was  done which showed
another 7 mm nodule in the upper left breast with minimal FDG
avidity that was  indeterminate. There was no disease elsewhere. A
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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mig. 1. Cut sections of excision biopsy of left breast nodule showing a homogenous
ellowish-tan appearance.
epeat ultrasound in our institution conﬁrmed the presence of this
odule. A vacuum-assisted biopsy was done with histology show-
ng melanoma with an identical histo- morphology (Fig. 3A) and
mmuno-histochemical proﬁle as the initial excision biopsy speci-
en. This case was further discussed at the sarcoma tumor board
nd as the impression was a primary multi-centric melanoma of
he breast, a mastectomy with a sentinel lymph node biopsy was
ecommended.
Prior to surgery, a comprehensive physical examination was
one to look for a primary cutaneous lesion and no abnormal-
ooking naevi was noted. A benign-looking scalp nodule and neck
odule were noted; both were excised and histology returned as
ntradermal melanocytic naevus and spongiotic dermatitis, respec-
ively. In addition, esophagogastroduodenoscopy, colonoscopy and
olposcopy were done to rule out mucosal melanoma and all were
ormal.
Just before the planned surgery, she reported a tiny stable sub-
utaneous nodule in her left upper anterior arm, which she had for
 months prior; it was well-deﬁned and mobile. This nodule was
xcised during the mastectomy. At the same time, a sentinel lymph
ode biopsy and immediate breast reconstruction with a latissimus
orsi ﬂap was done.
Histology of the breast showed a 1 mm focus of residual
elanoma at the biopsy site (Fig. 3B). Resection margins were unin-
olved by tumor, and all three sentinel lymph nodes were negative
or malignancy.
However, histology for the upper arm nodule showed the pres-
nce of a melanoma surrounded by a ﬁbrous capsule (Fig. 3C and
), which raised the possibility of metastatic melanoma in a com-
letely replaced lymph node. In all 3 nodules which tested positive
or melanoma, no overlying skin was involved, and this precluded
he usual melanoma staging by Clark’s or Breslow’s classiﬁcation.
As there were no other detectable lesions, a collective decision
as made with the patient for close clinical and radiologic surveil-
ance.
. Discussion
This patient presents with an interesting diagnostic conundrum
hat brings up certain pertinent aspects of melanoma.
When melanoma was ﬁrst detected in the breast parenchyma
n our patient, diagnostic considerations included that of a primary
elanoma in the breast versus metastatic deposits from an extra-PEN  ACCESS
rgery Case Reports 23 (2016) 77–81
mammary primary melanoma. Primary breast melanoma with no
overlying skin changes is unreported in literature, and to have two
concomitant primary lesions was highly unlikely. However, exten-
sive search failed to identify a primary cutaneous melanoma. Since
primary multi-centric breast melanoma was  still a viable etiology,
a mastectomy and sentinel lymph node biopsy was recommended.
Malignant tumors which metastasize to the breasts are rare and
only account for 0.5–2% of all malignant lesions in the breast. Of
these, melanomas, rhabdomyosarcomas, lymphomas remain the
more common tumors [1–3]. In our patient, these nodules were
very superﬁcial and hence may  have been subcutaneous, suggest-
ing a greater likelihood of being metastases instead of primary
lesions. The location of a lump in the breast does not help distin-
guish between a secondary deposit versus a breast primary [4].
Features of metastatic disease on breast imaging such as mam-
mograms or ultrasounds are often subtle and indistinguishable
from primary or benign breast lesions, as was the case in our
patient, and hence conﬁrmatory histological diagnosis is required
[5]. MRI  of the breasts has not been evaluated as a tool in differ-
entiating metastatic lesions from other lesions and hence was not
considered in our patient. Furthermore, a negative breast sentinel
lymph node biopsy with another lesion in the upper arm, possibly
a lymph node, suggests a primary lesion in the upper limb with
breast metastases. Thus far, there has been no strong predictive
factor identiﬁed for the development of breast metastasis from an
extra-mammary primary. However, in a review of 15 patients with
melanoma metastases in the breast, Akcay et al. did note that they
were all premenopausal [6]. Similarly a review of 8 patients by
Amichetti et al. found that at least half of their patients were pre-
menopausal [7]. This suggests a possible predisposition to breast
metastases in pre-menopausal melanoma patients. The prognosis
for such patients is often poor with the median survival approxi-
mately 10 months [7,8].
Close analysis of the upper arm nodule revealed a completely
contained lesion within a ﬁbrous capsule, located within subcuta-
neous fat. Other than the capsule-like sheath, there was  no residual
lymph node histo-architecture to support a nodal origin. Whilst it
was entirely possible that this was  a completely replaced lymph
node, the nodule’s location in the upper anterior arm, at a dis-
tance away from the axilla, was an atypical location for a lymph
node. Other alternatives considered include a possible melanoma-
in-transit lesion, subcutaneous metastasis or a primary intradermal
melanoma. An extensive search for a primary in the upper limb
proved futile, indicating that this could be a melanoma of unknown
primary.
A prospective study by Vizcaino et al. of 1571 patients showed
signiﬁcantly better 5-year overall survival for those with melanoma
of unknown primary compared to melanoma of known primary
(55% ± 6% v 44% ± 3%; P = 0.0021) in patients who had undergone
regional lymphadenopathy for palpable nodal metastasis [9]. Age
more than 60 years, increased number of tumor-involved nodes,
and male sex were also associated with a poorer prognosis [9].
In our patient, a completion lymphadenectomy was not done
for several reasons. Firstly, the diagnosis of the upper arm nod-
ule was not histologically certain—it could have been a completely
replaced lymph node or simply melanoma deposits with a ﬁbrous
response. In addition, the beneﬁt of axillary dissection in a clini-
cally negative axilla was unclear. PET scan also did not show any
other suspicious lesions in the axilla. Furthermore, after the prior
mastectomy, she had immediate breast reconstruction using the
latissimus dorsi. Access to the axilla could compromise the blood
supply to the ﬂap. Hence, the decision was  made for close clinical
surveillance with subsequent PET scans for recurrent disease. At
present, no viable adjuvant therapy has been shown to reduce the
risk of recurrence and prolong survival in such patients [9].
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Fig. 2. Hematoxylin and eosin stained sections of excision biopsy specimen of the left breast nodule showing a lobulated proliferation of sheets of epithelioid cells featuring
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ocally  the tumor cells display eccentric nuclei with hyaline cytoplasmic inclusion
elan-A (E). Focal positivity for HMB45 was  noted (F).
The postulation that the upper arm lesion could be a melanoma
ith a surrounding ﬁbrous response raises the possibility of this
eing either a primary intradermal melanoma, a very rare tumor
ndeed, or melanoma-in-transit (N2c) from a primary that has
ndergone regression, or a subcutaneous metastasis (M1a) from
n unknown primary.
Since the extensive search for a primary in the upper limb was
utile, a regressed primary lesion is a worthwhile consideration.
ompared to other cancers, melanoma is more likely to undergo
pontaneous regression. Partial regression of primary cutaneous
elanoma has been documented in 10–35% of cases, with complete
egression even rarer at a rate of 0.22–0.27% [10,11]. This incidence
ay  be under-reported in literature as reported cases of melanoma
f unknown origin (MUP) – report at an incidence of 4–6% in liter-
ture – might also be explained by the phenomenon of primary
umor regression [12–14].
The prognostic signiﬁcance of regressed melanomas is unclear.
tudies have shown a correlation between regressed primary
elanomas and nodal metastasis with the cause-and-effect rela-x5) (A), accompanied by scattered intracytoplasmic brownish pigment (X20) (B).
) (C). Immunohistochemistry showed strong and diffuse staining for S100 (D) and
tionship undeﬁned as yet [15]. Some have theorized that nodal
metastasis stimulated an immune response that causes regression
of the primary lesion. Lymphocytic inﬁltrates of histological spec-
imens from partially regressed melanomas have lent credence to
this theory with the presence of lymphocytes importance in sup-
porting an enhance immune response. [16,17]. It follows that nodal
metastasis would portend a poorer prognosis for these patients.
Some authors have found that regression is a negative prognostic
factor [11]. However, the survival of such patients is highly vari-
able with overall survival ranging from 6 week to 11 years [16].
Evidence to the contrary shows that regression may  actually have
little effect on the risk of metastasis, and that it is not regression
itself per say, but rather the degree of regression that has an effect
on propensity for metastasis. Emanuel et al. have found that lesions
with regression of >50–80% have a higher chance of metastasis
[15]. Other proposed causes of tumor regression include operative
trauma, infection, blood transfusions, vaccinations, and endocrine
factors, all of which were absent in our patient [18].
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Fig. 3. Hematoxylin and eosin stained sections showing a proliferation of tumor cells from follow up biopsy of small left breast nodule (x20) (A) and a residual focus of
t he lef
c (D). A
r
t
d
m
p
t
i
m
s
i
t
m
t
u
r
l
(
T
m
[
v
i
m
g
w
r
t
m
o
aumor  in the left completion mastectomy specimen (x5) (B). The excision biopsy of t
omposed of a sheet-like proliferation of tumor cells (x20, hematoxylin and eosin) 
If the arm nodule was melanoma-in-transit (N2c) from a
egressed primary, prognosis would then be more guarded for
he patient. Melanoma-in-transit are located in regional and sub-
ermal lymphatics along the route of spread from a primary
elanoma to their regional nodal basins. It has been shown to
ortend poorer outcomes with up to 75% eventually progressing
o nodal or distal disease or both [19]. Treatment options would
nclude surgical resection, isolation limb perfusion or infusion with
elphalan, or systemic chemotherapy. Surgical resection if pos-
ible is the mainstay of treatment, with adjuvant therapy with
nterferon-alpha or participation in clinical trials [19]. In light of
he absence of a primary lesion in our patient, the diagnosis of
elanoma-in-transit could not be conﬁdently made, and adjuvant
reatment was held off as their beneﬁts could not be ascertained.
While rare, primary dermal melanoma can occasionally sim-
late metastatic melonoma from an unknown primary. In a
etrospective review of 1800 patients by Beasly et al. the preva-
ence of patients diagnosed with a presumed metastatic melanoma
i.e. stage IV) to the skin was 0.61% with 8-year survival of 83%.
he survival rates for Bowen’s population far exceed the com-
only quoted 5–8% 5-year survival for stage IV melanoma patients
20]. This uncharacteristic prognostic data is further reinforced by
arious other case series which demonstrate 5 year survival rates
n excess of 80% for cutaneous metastases in unknown primary
elanoma patients [20,21]. The unprecedented survival data sug-
ests that the natural history for such patients differs from patients
ith stage IV melanomas as currently staged by the AJCC crite-
ia. These tumors may  not represent metastatic melanomas, and
he term ‘primary dermal melanoma’ was coined to refer to these
elanomas as primary lesions that have arisen within the dermis
r subcutaneous fat. It has been postulated that such lesions may
rise from non-epidermal melanocytes, or from melanocytes asso-t arm lump showed an encapsulated tumor nodule (x5, hematoxylin and eosin) (C),
ll of them showed a similar appearance to that of the initial excision biopsy.
ciated with deeper appendagal structures [21]. However, the true
origin of such tumors remains nebulous. Due to the vast differ-
ence in prognosis, it is important to make a distinction between
primary dermal melanoma and metastatic melanoma when con-
fronted with a melanoma within the subcutaneous tissue or dermis.
Unfortunately, there have been no reliable histo-pathologic or
immune-histochemical differences noted thus far, and such a
diagnosis must always be considered when confronted with a
melanoma conﬁned to the dermis or subcutis [22].
For our patient, the prognosis is unclear—the outcome associ-
ated with melanoma of unknown primary or even possible primary
dermal melanoma balances or even outweighs the negative prog-
nostic signiﬁcance of breasts metastases remains to be seen.
In conclusion, this case report presents a rare and unique diag-
nostic conundrum in a patient with breast melanoma and two  other
cutaneous lesions in the upper limb. It illustrates that the presence
of a melanoma in the breast should prompt a close and meticulous
search for a primary lesion and for potential signs of metastasis in
nodal basins and common metastatic sites. This should be done via
clinical examination as well as appropriate imaging studies such as
PET-CT, CT scans or MRI  scans. We explore the notion that encap-
sulated subcutaneous nodules can be attributed to replaced lymph
nodes or subcutaneous melanoma either secondary to metastasis
from an unknown primary or as a primary dermal melanoma. The
various permutations should be considered, especially in patients
with atypical presentations such as ours, such that a suitably appro-
priate management and follow-up plan can be tailored.Conﬂicts of interest
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